Market analytics company, ResearchAndMarkets, forecasts that the veterinary rapid testing market segment will reach a value of $949.7 million globally in 2027. The estimate is revised after the impact of COVID-19, but still represents a CAGR growth of 6.8%. The 2020 estimated value was $600.6 million.
Within the market, rapid testing is expected to grow within hospitals and clinics at a CAGR rate of 7.1%, and reach $645.2 million value by 2027. The pharmacy segment dipped with the impact of COVID-19, and the forecast is revised to a CAGR of 6.1% across the next 7 years, according to ResearchAndMarkets.
In the US market, the segment is valued at $162.4 million in 2020. China is anticipated to reach a value of $207.8 million with a 10.3% CAGR by 2027.
List
Add
Please enter a comment